Form 4 holding
Chief Patient Officer
ARDELYX, INC.
- Security class
- Common Stock
- Shares / value
- 378,195
- Estimated value
- $2,265,009
- Report date
- 18 Jun 2026
- Price
- $5.99
- Ownership
- Direct
Laura A. Williams
Insider Reports History
- Reporting-owner location
- Boston, MA
- Latest reporting-owner signature
-
/s/ Felecia Ettenberg, Attorney-in-Fact for Laura A. Williams
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Laura A. Williams
Form 4 holding
Chief Patient Officer
ARDELYX, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 31,000
- Estimated value
- $365,864
- Report date
- 18 Jun 2026
- Price
- $2.32
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
IMARA Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 8,500
- Estimated value
- Report date
- 02 Jun 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Laura A. Williams
4
ARDX
ARDELYX, INC.
- Report period
- 18 Jun 2026
- Transactions
- 3
- Transaction value
- -$490,487
- Accepted by SEC
- 22 Jun 2026, 16:01
- Role
- Chief Patient Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 21 May 2026
- Transactions
- 4
- Transaction value
- -$43,804
- Accepted by SEC
- 22 May 2026, 16:09
- Role
- Chief Patient Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 20 Feb 2026
- Transactions
- 2
- Transaction value
- -$47,803
- Accepted by SEC
- 23 Feb 2026, 20:47
- Role
- Chief Patient Officer and interim Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 23 Jan 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 26 Jan 2026, 16:23
- Role
- Chief Patient Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 08 Jan 2026
- Transactions
- 3
- Transaction value
- -$299,400
- Accepted by SEC
- 09 Jan 2026, 18:59
- Role
- Chief Patient Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 21 Nov 2025
- Transactions
- 1
- Transaction value
- -$35,580
- Accepted by SEC
- 25 Nov 2025, 16:35
- Role
- Chief Patient Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 26 Aug 2025
- Transactions
- 4
- Transaction value
- -$440,180
- Accepted by SEC
- 28 Aug 2025, 19:30
- Role
- Chief Patient Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 21 Aug 2025
- Transactions
- 1
- Transaction value
- -$37,138
- Accepted by SEC
- 25 Aug 2025, 21:13
- Role
- Chief Patient Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 20 May 2025
- Transactions
- 1
- Transaction value
- -$26,207
- Accepted by SEC
- 22 May 2025, 21:55
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 25 Feb 2025
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 27 Feb 2025, 18:06
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 20 Feb 2025
- Transactions
- 1
- Transaction value
- -$27,783
- Accepted by SEC
- 21 Feb 2025, 18:56
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 20 Nov 2024
- Transactions
- 1
- Transaction value
- -$35,316
- Accepted by SEC
- 22 Nov 2024, 18:37
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 20 Aug 2024
- Transactions
- 1
- Transaction value
- -$43,437
- Accepted by SEC
- 22 Aug 2024, 18:28
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 05 Jun 2024
- Transactions
- 4
- Transaction value
- -$758,080
- Accepted by SEC
- 07 Jun 2024, 18:29
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 21 May 2024
- Transactions
- 1
- Transaction value
- -$37,446
- Accepted by SEC
- 23 May 2024, 16:21
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 03 May 2024
- Transactions
- 3
- Transaction value
- -$303,874
- Accepted by SEC
- 07 May 2024, 16:48
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 20 Feb 2024
- Transactions
- 1
- Transaction value
- -$42,008
- Accepted by SEC
- 22 Feb 2024, 16:56
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 16 Jan 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 18 Jan 2024, 16:39
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 20 Nov 2023
- Transactions
- 1
- Transaction value
- -$11,259
- Accepted by SEC
- 22 Nov 2023, 17:22
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 15 Nov 2023
- Transactions
- 1
- Transaction value
- -$99,998
- Accepted by SEC
- 17 Nov 2023, 17:30
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 21 Aug 2023
- Transactions
- 1
- Transaction value
- -$9,203
- Accepted by SEC
- 23 Aug 2023, 16:46
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 27 Jun 2023
- Transactions
- 1
- Transaction value
- -$83,632
- Accepted by SEC
- 29 Jun 2023, 19:22
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 23 May 2023
- Transactions
- 1
- Transaction value
- -$9,436
- Accepted by SEC
- 25 May 2023, 08:51
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 21 Feb 2023
- Transactions
- 1
- Transaction value
- -$9,564
- Accepted by SEC
- 24 Feb 2023, 16:41
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 05 Jan 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 06 Jan 2023, 15:23
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 22 Nov 2022
- Transactions
- 3
- Transaction value
- -$2,419
- Accepted by SEC
- 23 Nov 2022, 15:13
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 31 Aug 2022
- Transactions
- 1
- Transaction value
- +$1,856
- Accepted by SEC
- 01 Sep 2022, 19:03
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 22 Aug 2022
- Transactions
- 2
- Transaction value
- -$1,255
- Accepted by SEC
- 24 Aug 2022, 17:42
- Role
- Chief Medical Officer
- Next action
- Open filing details
3
ARDX
ARDELYX, INC.
- Report period
- 15 Jun 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 23 Jun 2022, 18:49
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
ELVN
IMARA Inc.
- Report period
- 02 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 Jun 2022, 20:22
- Role
- Director
- Next action
- Open filing details
4
ELVN
IMARA Inc.
- Report period
- 29 Jun 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 30 Jun 2021, 17:18
- Role
- Director
- Next action
- Open filing details
3
ELVN
IMARA Inc.
- Report period
- 29 Jun 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 30 Jun 2021, 17:07
- Role
- Director
- Next action
- Open filing details